Proteins containing ubiquitin-binding domains (UBDs) interact with ubiquitinated targets and regulate diverse biological processes, including endocytosis, signal transduction, transcription and DNA repair 1-3 . Many of the UBD-containing proteins are also themselves monoubiquitinated, but the functional role and the mechanisms that underlie this modification are less well understood. Here, we demonstrate that monoubiquitination of the endocytic proteins Sts1, Sts2, Eps15 and Hrs results in intramolecular interactions between ubiquitin and their UBDs, thereby preventing them from binding in trans to ubiquitinated targets. Permanent monoubiquitination of these proteins, mimicked by the fusion of ubiquitin to their carboxyl termini, impairs their ability to regulate trafficking of ubiquitinated receptors. Moreover, we mapped the in vivo monoubiquitination site in Sts2 and demonstrated that its mutation enhances the Sts2-mediated effects of epidermal-growth-factor-receptor downregulation. We propose that monoubiquitination of ubiquitin-binding proteins inhibits their capacity to bind to and control the functions of ubiquitinated targets in vivo.
are recruited to activated epidermal growth factor (EGF) and plateletderived growth factor receptors via the ubiquitin ligase Cbl and bind to ubiquitinated receptor complexes through their amino-terminal ubiquitin-associated (UBA) domains. Both of these steps are required for the ability of Sts proteins to interfere with EGF receptor (EGFR) endocytosis and degradation, but the molecular mechanisms that underlie regulation of Sts in these processes remain elusive.
Monoubiquitination of Sts1 and Sts2, which is observed as a shift in their mobility on SDS-PAGE gels and which corresponds to the addition of a monoubiquitin to Sts1 and Sts2, is potently enhanced by overexpression of monoubiquitin in the cell (Fig. 1a) . As several UBDs promote ubiquitination of their host proteins 3 , we investigated whether ubiquitination of Sts1 and Sts2 was also dependent on the presence of functional UBA domains. Mutation of glycine (G) and phenylalanine (F) in the highly conserved MGF motif of the UBA of Sts1 (Sts1-GF/AA; Fig. 1b ) abolished binding to monoubiquitin (Fig. 1b) , as well as its monoubiquitination (Fig. 1a , b, lower panel). The same mutations did not completely block ubiquitin binding of Sts2 (Fig. 1b) . However, mutation of Lys 40 in the UBA of Sts2 impaired its interaction with monoubiquitin ( Fig. 1b) and monoubiquitination of Sts2 (Fig. 1, b) . These results show that the UBA domains of Sts1 and Sts2 are crucial determinants of both their ubiquitin binding and monoubiquitination, and provide the first example of proteins that undergo monoubiquitination that is mediated by UBA domains.
To identify the lysine(s) in Sts proteins that had been monoubiquitinated in vivo, we purified human Sts2 by immunoaffinity columns and subjected the monoubiquitinated form to trypsin digestion and liquid chromatography-tandem mass spectrometry (LC-MS-MS) analysis (see Supplementary Information, Fig. S1 ). We identified Lys 202, which accounted for the majority of incorporated ubiquitin in the Sts2 molecule, in addition to three minor sites (Lys 15, Lys 309 and Lys 358) ( Fig. 1c ; and see Supplementary Information, Fig. S1 ). Mutation of Lys 202 to arginine (Sts2 K202R ) efficiently impaired Sts2 monoubiquitination (Fig. 1c) , supporting the notion that Lys 202 is the main monoubiquitination site of Sts2 in vivo.
Monoubiquitination can have several functional consequences for the targeted protein, including changes in binding properties, subcellular localization and activity [1] [2] [3] . Using in vitro ubiquitin-binding assays, we found that monoubiquitinated Sts1 and Sts2 did not interact with exogenous monoubiquitin (Fig. 2a) . We tested whether this phenomenon is also true for other endocytic adaptor proteins that are known to be monoubiquitinated, such as the ubiquitin interacting motif (UIM)-containing Eps15 and Hrs 7, 11, 12 . Indeed, monoubiquitinated forms of Eps15 (Fig. 2b) and Hrs (Fig. 2c) did not bind to glutathione S-transferase (GST)-fused monoubiquitin, whereas the same unmodified protein efficiently did so. To further validate these findings, we created permanently monoubiquitinated proteins by fusing a ubiquitin moiety to the carboxy-terminal part of Sts1, Sts2, Eps15 and Hrs (Fig. 2f) . Sts1-ubiquitin, Sts2-ubiquitin, Eps15-ubiquitin and Hrs-ubiquitin chimerae maintained their ability to interact with non-ubiquitinated targets, including Cbl, epsin and STAM, respectively (see Supplementary  Information, Fig. S2 ). However, when tested for binding to GST-fused ubiquitin, all ubiquitin chimerae were impaired in their ability to interact with exogenous ubiquitin (Fig. 2b-e) . To exclude that this effect was due to misfolding imposed by the fusion of ubiquitin to these proteins, we introduced a mutation in the conserved hydrophobic patch of ubiquitin (Ile44) that abolishes its binding to known UBDs 3 , including the UBA of Sts1 and Sts2 (Fig. 2d, e) . Mutation of Ile44 to Ala in the ubiquitin chimerae completely restored the ability of Sts1, Sts2, Eps15 and Hrs to bind to GST-monoubiquitin ( Fig. 2b-e) . These data support the concept that monoubiquitination of both UIM-and UBA-containing proteins neutralizes their ubiquitin-binding capacities.
We hypothesized that the loss of ubiquitin binding of the monoubiquitinated proteins might be due to an intramolecular interaction between the UBD and the monoubiquitin on the same molecule, thereby preventing its binding to neighbouring ubiquitin targets. Given the fact that Eps15, Hrs and Sts proteins are able to dimerize or oligomerize, and are also found in multimeric protein complexes in cells 2, 9 , it is possible that their monoubiquitinated forms engage in intramolecular (within the single molecule), intermolecular (between different molecules of the homo-oligomeric complex) or transmolecular (between different proteins in heterologous complexes) interactions. We therefore investigated whether the intramolecular binding between monoubiquitin and the UBA of Sts1 and 2 is sufficient for its auto-inhibition. Dimerizationdeficient Sts1-∆PGM (phosphoglycerate mutase domain) and its ubiquitin chimera were expressed in Escherichia coli, which lacks the ubiquitin conjugation system as well as UBD-containing proteins. As shown in Fig. 3a , bacterially expressed Sts1-∆PGM readily interacted with GST-ubiquitin, whereas Sts1-∆PGM-ubiquitin was impaired in binding to exogenous ubiquitin. When the same constructs were subjected to chemical cross-linking under conditions in which wild-type Sts1 was completely cross-linked, there was no detectable dimerization of Sts1-∆PGM-ubiquitin (Fig. 3b) . This result confirms that there is no biochemical evidence for intermolecular interactions between the UBA of monomeric Sts1-∆PGM and the attached ubiquitin to another Sts1-∆PGM molecule. The same block in ubiquitin binding was also found in the context of the full molecule, and mutation of I44A in Sts1-ubiquitin was able to restore binding to ubiquitin (see Supplementary Information,  Fig. S2e) . Last, to directly confirm the conformational change resulting from intramolecular UBD-ubiquitin interactions in ubiquitinated Sts1-2-∆PGM, we took advantage of fluorescence resonance energy transfer (FRET) technology. We attached the FRET donor cyan fluorescence protein (CFP) to the C terminus and the acceptor citrine to the amino terminus of Sts2-∆PGM (Cit-Sts2∆PGM-CFP, Fig. 3c ). First, we confirmed that this construct retained the features of the untagged variant described above. For this purpose, we checked its ubiquitination as well as its ubiquitin-binding properties, and found that Cit-Sts2∆PGM-CFP behaved normally in all assays (see Supplementary Information,  Fig. S2f ). When expressed in HEK293T cells, this construct led to a FRET signal that was significantly higher than when Cit-Sts2-∆PGM and Sts2-∆PGM-CFP were co-expressed (Fig. 3d) , indicating that citrine and CFP are in close proximity. Importantly, mutation of the major ubiquitination site Lys 202 to arginine resulted in a decrease of the FRET signal to almost background level. The same decrease was observed in a ubiquitin-binding-deficient mutant in which Lys 40 was mutated to arginine (Cit-Sts2∆PGM-UBA*-CFP; Fig. 3c, d ). This indicates that, in these mutants, citrine and CFP are too distant from each other to enable energy transfer. These data demonstrate that intramolecular interactions between monoubiquitin and the UBA domain in Sts-∆PGM occur and are sufficient to block the ubiquitin-binding ability of Sts1 and 2.
Our experimental results were additionally evaluated by comparing the thermodynamic properties of intramolecular versus transmolecular ubiquitin binding. The presented biophysical estimates and mathematical equations indicate that monoubiquitinated Sts1 and Sts2 in solution will exclusively bind intramolecularly to their own ubiquitin and not to exogenous ubiquitin (see Supplementary Information). However, if these proteins are localized on scaffolds or platforms (for example, on endosomes), they can engage in transmolecular interactions as the equilibrium between intramolecular versus transmolecular binding depends on the geometrical arrangement of the complex and on the number of ubiquitins that are attached to the target protein (see Supplementary  Information) . Notably, there will be a dynamic exchange between the intramolecular and transmolecular bound state of UBD-containing Hrs− Ub
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Pull-down TCL Eps15−Ub I44A with HA-ubiquitin, Myc-Hrs-ubiquitin or Myc-Hrs-ubiquitin I44A , were subjected to GST-ubiquitin pull-down assays, followed by western blotting. (d) Lysates of HEK293T cells overexpressing Flag-Sts1 wild type or the indicated chimerae were subjected to GST-ubiquitin pull-down experiments and analysed by western blotting. (e) Flag-Sts2 wild type or the indicated chimerae were subjected to GST-ubiquitin pull-down experiments and analysed by western blotting. (f) Schematic representation of ubiquitin chimerae that were used for the described experiments. EH, Eps15-homology domain; FYVE, PtdInsP 3 binding domain; SH3, Src-homology 3 domain; VHS, Vps27/Hrs/STAM domain.
proteins that allows a flexible adaptation to changes in the local environment and might also explain the observations that Sts-ubiquitin chimerae are monoubiquitinated to a certain extent (data not shown).
Having created the Sts2-ubiquitin chimera, which mimicks permanent monoubiquitination and the Sts2 mutant (Sts2 K202R ) that is not monoubiquitinated, we were able to analyse the functional importance of monoubiquitination of Sts proteins in cells. Sts1 and Sts2 have been shown to inhibit EGFR degradation by binding to the ubiquitin ligase Cbl and interacting with ubiquitinated receptor complexes via their UBA domains 9 . To reliably detect differences in the ability of Sts2, Sts2-ubiquitin and Sts2 K202R mutant to interfere with EGFR degradation even in the presence of endogenous Sts1, we overexpressed them along with EGFR. We made use of the green fluorescent protein (GFP)-tagged EGFR, the degradation kinetics of which are the same as those of wild-type and endogenous receptors (data not shown). Expression of Sts2 in HEK293T cells caused stabilization and accumulation of EGFR-GFP following ligand stimulation (Fig. 4a) . By contrast, overexpression of Sts2-ubiquitin, but not of the Sts-ubiquitin I44A , chimerae in cells caused significantly decreased EGFR levels (Fig. 4a) . Equivalent data were obtained for Sts1 and Sts1-ubiquitin chimerae on EGFRs at steady state (data not shown) and after EGF stimulation (see Supplementary Information, Fig. S3a ). More importantly, Sts2 K202R , which cannot be monoubiquitinated in cells, stabilized EGFRs more significantly than Sts2 wild type following EGF stimulation (Fig. 4a) , indicating that monoubiquitination of Sts2 inhibits its capacity to block ligand-induced degradation of EGFRs. Sts2 therefore represents the first UBD-containing protein, which is monoubiquitinated at a defined lysine residue and the mutation of which is functionally significant in vivo.
To investigate whether a similar negative regulation by monoubiquitination can be found in other components of the endocytic sorting machinery, we tested the role of monoubiquitination of Hrs in Hela cells. Hrs has been previously implicated in the sorting of ubiquitinated transmembrane receptors into clathrin-coated microdomains of the early endosome [13] [14] [15] . Because overexpression of Hrs inhibits b a 
anti-GFP recycling of an endocytosed ubiquitin-transferrin receptor (TfR) chimera (ubiquitin-TfR) through a mechanism that requires ubiquitin binding 4 , we investigated whether monoubiquitination of Hrs would promote recycling of ubiquitin-TfR. For this purpose, HeLa cells were co-transfected with ubiquitin-TfR and the indicated Hrs constructs, and the intracellular accumulation of endocytosed transferrin following a 2-h chase period was measured. Overexpression of wild-type Hrs or the Hrs-ubiquitin I44A chimera led to a strong cellular retention of transferrin, whereas Hrs-ubiquitin, which mimics a mutant with a non-functional UIM, Hrs-S270E, was unable to retain transferrin in endosomes ( Fig. 4b ; see Supplementary Information, Fig.  S4c ). The ability of Hrs to bind and recruit clathrin is thought to be important for its function as an endosomal sorting receptor 16 , and we considered the possibility that ubiquitination could affect clathrin recruitment to endosomes. However, overexpression of both Hrs and the Hrs-ubiquitin chimera equally recruited clathrin to early endosomes, whereas Hrs(1-706), which lacks the clathrin-binding C terminus, did not cause any clathrin recruitment (see Supplementary  Information, Fig. S3b ). Taken together, monoubiquitination of Hrs does not significantly affect its ability to recruit clathrin to early endosomes, but leads to functional inactivation of the UIM domain, thereby affecting trafficking of ubiquitin-TfR. Recent studies have shed new light on the possible functions of Eps15, Eps15R and epsin in regulating the endocytic route taken by ubiquitinated cargoes in cells 17, 18 .
I44A chimerae showed significant co-localization with EGFR-positive vesicles, whereas Eps15-ubiquitin chimerae were diffusely expressed in the cytoplasm and were not associated with endocytosed EGFRs (Fig. 5a ; see Supplementary Information, Fig. S4 ). These data indicate that monoubiquitination of Eps15 inhibits its association and co-localization with EGFR-containing endocytic vesicles.
Our results demonstrate that monoubiquitination of UBD-containing proteins triggers intramolecular interactions with the UBDs, thereby preventing them from binding in trans to ubiquitinated targets. This is a common phenomenon for several UBDs, including UBA (Fig. 2) and UIM (Fig. 2) , as well as the novel UBM and UBZ domains 21 . Changes in their ubiquitination status seem to induce a conformational switch from a ubiquitin-binding state of these proteins to an intramolecular monoubiquitin-inhibited state (Fig. 5b) . This could explain how UBD proteins that constitute the endocytic sorting machinery can dynamically exchange their ubiquitinated cargoes along the endosomal compartments. Although the main outcome of monoubiquitination of UBD proteins is inhibition of their ubiquitin-binding capacity, broader functional consequences can also be conceived, including changes in enzymatic activity 1, 3 , binding properties 17, 22 or intracellular localization (Fig. 5a) . Biophysical calculations reveal an important difference in the behaviour of proteins in solution and of proteins that are anchored on scaffolds. Freely diffusible monoubiquitinated UBD-containing proteins will invariably engage in intramolecular UBD-ubiquitin interactions due to the high local concentration of ubiquitin being attached to the same molecule. However, a significant pool of proteins is embedded into multimeric complexes in vivo, which constrains the mobility of the protein components. In such conditions, the reaction equilibrium shifts towards transmolecular interactions (Fig. 5b) . At the same time, the attached monoubiquitin becomes accessible and is either cleaved off or, alternatively, can be available as an additional binding surface, thereby positively promoting the assembly of ubiquitin-linked protein networks. Taken together, ubiquitin plays a dual role in endocytic pathways: it acts as a sorting tag on trafficking cargoes and as a regulatory signal on UBD-containing proteins. -transferrin (Tf) was internalized for 15 min. After a 2-h chase period in the presence of cycloheximide and leupeptin, the cells were processed for confocal microscopy. Cell-associated Alexa 568 -transferrin was quantified as described in Methods. Error bars denote ± SEM. Ub-TfR: n = 10; Ub-TfR + Hrs: n = 40; Ub-TfR + Hrs-Ub: n = 40; Ub-TfR + Hrs
S270E
: n = 25.
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METHODS
Reagents, cells, plasmids and antibodies.
We generated a polyclonal antibody that recognizes the C-terminal peptide of Sts1: CPTGGFNWRETLLQE. Antibodies against extracellular-regulated kinase (ERK)-2 (C14) and ubiquitin (P4D1) were purchased from Santa Cruz (Heidelberg, Germany), mouse anti-HA (12CA5) antibodies were obtained from Roche (Mannheim, Germany) and anti-FLAG (M2 and M5) antibodies were obtained from Sigma (Taufkirchen, Germany). Anti-FLAG M2 antibodies were used for immunoprecipitation and M5 for western blotting. Anti-Cbl (RF) and anti-EGFR (RK2) antibodies were described previously. Affinity-purified rabbit antibodies against recombinant Hrs have been described previously 16 . Mouse monoclonal antibodies against the human transferrin receptor (B3-25) were obtained from Boehringer Mannheim (Mannheim, Germany). Cy2-and Cy5-labelled secondary antibodies were obtained from Jackson Immunoresearch (West Grove, PA). Alexa 568 -transferrin was obtained from Molecular Probes (Eugene, OR).
EGF was purchased from Peprotech (London, UK). For overexpression experiments, cells were transfected using Lipofectamine Reagent (Invitrogen) according to the manufacturer's instructions. Thirty-six hours after transfection, cells were either lysed or starved for an additional 12 h and then subjected to stimulation with 50 ng ml -1 EGF for the indicated times, and then lysed. Constructs for expressing GFP-EGFR, EGFR, HA-c-Cbl and HA-tagged ubiquitin have been described previously. The EGFR-ubiquitin, pcDNA3-Flag-epsin-1 and the pcDNA3-Flag-Eps15 chimera constructs were kindly provided by P.P. Di Fiore (FIRC, Italy) . The pcDNA3-Myc-Hrs and pcDNA3-Myc-Hrs-UIM S270E constructs have been described recently 4 . HA-tagged hStam2 was kindly provided by S. Urbe (University of Liverpool, UK). The constructs for mammalian expression of Sts1 were all generated by polymerase chain reaction (PCR) using pcDNA3-FLAG (Invitrogen) and have been described recently 9 . The Sts1-ubiquitin and Sts2-ubiquitin chimerae were generated by subcloning the cDNAs for ubiquitin wild-type or I44A mutant, and then amplification by PCR in frame with the 3′ terminus of Sts1-2 or their deletions that had previously been subcloned into pcDNA3-FLAG. The stop codon in the sequence of Sts1-Sts2 was removed by mutagenesis to allow expression of the corresponding chimeric proteins. The same procedure was applied to generate Hrs-ubiquitin and Eps15-ubiquitin chimerae. For bacterial expression of Sts1, Sts1-ubiquitin, Flag-Sts1∆PGM and Flag-Sts1∆PGM-ubiquitin were cloned into the SalI and NotI sites of the pET24-SUMO vector and were expressed in BL21 cells according to the manufacturer's instructions (Lifesensor, Malvern, PA). GST Cbl-CT, containing the proline-rich sequences of Cbl (amino acids 450-860 of human c-Cbl), was expressed in BL21 cells and purified as described previously 9 . The constructs used in the FRET experiments were generated by subcloning citrine into the NheI and HindIII sites of pcDNA3-CFP and subsequent insertion of Sts2, Sts2 K202R , Sts2∆PGM and Sts2∆PGM K202R into the KpnI and BamHI sites of the same vector. pcDNA3-CFP and pcDNA3-citrine were kindly provided by P. Bastiaens (EMBL, Germany).
HEK293T, CHO, Hela and CCL-185 cell lines were purchased from the American Type Culture Collection and grown according to the manufacturer's instructions.
Biochemical assays. For ubiquitin-binding assays, HEK293T cells were transfected with the indicated Flag-tagged Sts1-2 constructs, lysed for 10 min on ice in lysis buffer (50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Triton-X-100, 25 mM NaF, 10 µM ZnCl 2 , pH 7.5) containing protease inhibitors (aprotinin, leupeptin and PMSF). Cell lysates were collected, centrifuged for 15 min (13,000g) to remove the insoluble fraction and incubated with GST-ubiquitin or GST coupled to Glutathione sepharose 4B (Amersham Biosciences, Frieburg, Germany) for 4 h at +4 °C. After incubation, the sepharose matrix was washed three times with lysis buffer. Bound proteins were analysed by immunoblotting using α-Flag antibodies.
Chemical cross-linking was performed by incubating the cell lysates with 2 mg ml -1 BS 3 (Pierce, Bonn, Germany) for 30 min at room temperature. The reaction was stopped by adding Laemmli buffer. Cross-linked proteins were then analysed by SDS-PAGE and immunoblotting.
Mass spectrometry. Protein bands containing monoubiquitinated Sts1 or Sts2 were excised from the gel and subjected to in-gel reduction, alkylation, trypsin digestion and subsequent sample desalting, as described previously (a) Eps15 and Eps15-ubiquitin I44A strongly colocalized with endoctyosed endogenous EGFR in Hela cells that have been stimulated with 100 ng ml -1 EGF for 5 min, whereas Eps15-ubiquitin was mostly cytoplasmic. Colcalization was quantified by counting endosomal vesicles that were double-positive vesicles for endogenous EGFR and the indicated constructs. Statistical analysis was performed using the two-sided Wilcoxon test: Eps15 WT > Eps15-ubiquitin (***, P < 0.0001); Eps15-ubiquitin < Eps15-ubiquitin I44A (***, P < 0.0001); Eps15 WT = Eps15-ubiquitin I44A (P = 0.34). Eps15: n = 21; Eps15-ubiquitin: n = 21; Eps15-ubiquitin I44A : n = 21. (b) Proposed mechanism of monoubiquitin-mediated regulation of endocytic adaptor proteins: In solution, monoubiquitinated UBD-containing proteins adopt a closed, auto-inhibited conformation due to intramolecular UBD-ubiquitin interactions. This pool of proteins will be inactive with respect to transmolecular binding to ubiquitinated targets; for example, cargo sorting. At the same time, a significant pool of the adaptor protein is captured on scaffolds or platforms (for example, on endosomes or complexes on EGFRs). Depending on the protein, different scenarios will take place: Monoubiquitination precludes localization of the adaptor on the scaffold (as is the case for Eps15). Therefore, the adaptor must be de-ubiquitinated to actively participate in cargo sorting. Alternatively, the monoubiquitinated adaptor can be recruited to the scaffold but transmolecular UBD interactions are dependent on the geometrical arrangement of the domains. Multiple monoubiquitination of cargo can, additionally, shift the equilibrium from intra-to transmolecular ubiquitin binding.
transform (LTQ-FT) mass spectrometer (Thermo Electron, Bremen, Germany), which was equipped with a nanoelectrospray ion source (Proxeon Biosystems, Odense, Denmark), essentially as described previously 24 . Protein identification was performed with the Mascot software package (Matrix Science, London, UK).
FRET experiments. FRET measurements were performed as recently described 25 . Briefly, HEK293T cells were transfected with either Cit-Sts2∆PGM + Cit-Sts2∆PGM-CFP, Cit-Sts2∆PGM-CFP, Cit-Sts2∆PGM K204 -CFP or CitSts2∆PGM-UBA*-CFP. Following 24-30 h of transfection, cells were lysed and the lysates were analysed using a Wallac Victor 3 1420 multilabel counter (Perkin Elmer, Wiesbaden, Germany), using the following filters: CFP: 430 nm/8 nm (excitation), 486 nm/10 nm (emission); citrine: 510 nm/10 nm (excitation), 535 nm/25 nm (emission). The FRET signal is shown as FRET-CFP in arbitrary units, normalized within each experimental replicate so that the maximum signal equals 1. 
Measurement of Eps15-EGFR colocalization.
Hela cells were transfected with 2 µg DNA using MATra transfection reagent (IBA, Göttingen, Germany) and seeded onto coverslips 12 h post-transfection. After serum starvation for 15 h, the cells were stimulated for 5 min with 100 ng ml -1 EGF. Cells were fixed with 4% PFA, permeabilized with digitonin and stained for EGF receptor with a monoclonal mouse antibody (MAb 108; 10 µg ml -1 ) and for Flag-Eps15 using a polyclonal anti-Flag antibody (1:300; Sigma). Secondary antibodies conjugated with fluorochromes (anti-rabbit-FITC and anti-mouse-Cy3; Jackson Immunoresearch) were used to visualize the primary antibodies. Images were prepared using a Zeiss 510 Meta confocal microscope.
EGFR downregulation assays using flow cytometry. HEK293T cells were transfected with EGFR-GFP and either Sts1, Sts1-ubiquitin, Sts1-ubiquitin I44A or empty vector (control) in 10 cm cell culture dishes. After 24 h, cells were split into 12-well dishes and starved overnight in serum-free medium. The following day, cycloheximide (20 µg ml -1 ) was added to the cells 2 h before they were left unstimulated or were incubated with EGF (50 ng ml -1 ) for 30 or 60 min at 37 °C. After stimulation, cells were harvested and analysed using the Epics XL flow cytometer (Beckman-Coulter, Krefeld, Germany). For each sample, 10,000 GFPpositive cells were analysed to determine the amount of remaining EGFR. Mean fluorescence intensity of each sample was calculated using Expo 32 ADC software. Equal expression of the transfected proteins was checked by immunoblotting. anti-Sts1 S t s 1
anti-GFP -C F P f Figure S2 Monoubiquitylation of Sts1/2, Hrs and Eps15 does not affect interactions with Cbl, Stam2 or Epsin, respectively. (a) 293T lysates co-expressing Cbl and either of the indicated constructs were subjected to co-immunoprecipitation using a Flag(M2)-antibody followed by immunoblotting. (b) 293T lysates co-expressing Cbl and either Sts2 wild type, Sts2SH3* (a mutant unable to bind to Cbl) or Sts2Ub were subjected to co-immunoprecipitation using a Cbl-specific antibody followed by immunoblotting. (c) 293T lysates co-expressing the indicated Eps15 constructs and epsin1 were subjected to co-immunoprecipitation using epsin-specific antibodies and analyzed by immunoblotting using anti-Flag antibodies. (d) 293T lysates overexpressing the indicated Hrs constructs with or without HA-Stam2 were subjected to co-immunoprecipitation using an α-Myc antibody. (a) Bacterially expressed Sts1-Ub is blocked in Ub-binding. Bacterial lysates containing Sts1, Sts1-Ub or Sts1-UbI44A were subjected to GST pulldowns using GST-Ub (upper right panel) and GST-Cbl-CT (lower right panel). Precipitated proteins were then analyzed by immunoblotting. (f) Characterization of dimerization-deficient Sts-∆PGM constructs used for FRET. Attachment of Citrine (Cit) to the N-terminus and CFP to the C-terminus of Sts2-∆PGM constructs does not affect their ubiquitylation or ubiquitin binding properties. Cell lysates from 293T cells expressing the indicated constructs were subjected to GST-Ub pull downs and analyzed by western blotting.
If intramolecular and transmolecular complex share the same binding strength, then k 1reverse and k 2reverse will be equal and cancel out. For the sake of the argument, we can split the rate constant k 2f orward into two virtual constants: k 2f orward = K hit × k react , where K hit is associated with the initial approach of the two reacting molecules and k react is the rate constant of their actual transformation into a bound complex. We can now choose the two virtual constants in such a way that k react = k 1f orward , in which case our equation becomes K 2 /K 1 = K hit . Assuming that diffusion is rapid compared to complex formation K hit will then be the equilibrium constant associated with the formation of a "pre-reaction complex", PRE, which behaves in exactly the same way as if the two interacting domains were part of the same molecule. The original rate equation
then becomes
The domains in the intramolecular reaction are at most a distance d max apart, defining a "reactive volume" V = 
)
3 in which the intramolecular reaction has to take place. We assume that any ubiquitylated cargo, UC, that enters a volume V in the vicinity of a ubiquitin binding domain, UA open , will behave as if the consequent reaction is intramolecular. This is a conservative assumption that almost certainly will lead to an over-estimate of the rate of the transmolecular complex formation. The concentration of "pre-reaction complex" in a homogeneous dilute solution at any given time is then given by
where N A is Avogadro's number. Here, [UC] V N A is the number of UC molecules within the "reactive volume" V of a single UA open molecule, which at low concentrations of UC is a good approximation for the fraction of UA open molecules that have at least one UC molecule in their vicinity V . From 7, 8 and 9 we then obtain
and consequently
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UBA Ub
Ub free K202 3nm 4nm 23nm "reactive volume" = V Figure 1 : Estimate of the geometrical dimensions of the intramolecular ubiquitin binding reaction in STS-1. The approximate size of ubiquitin and of the ubiquitin binding domain is based on X-ray structures, the maximal length of the intervening sequence is estimated as the length of a fully extended alpha-helix. Combining these estimates leads to a rough (and conservative) estimate for the "reactive volume" V described in the text.
Based on X-ray data we know that the diameter of the UBD is about 3nm and that of ubiquitin about 4nm. In the intramolecular reaction the two domains are separated by a 150 amino acid linker between UBD and K202 of STS-2, which in an extended all-alpha helix conformation would have a length of 23nm. Thus, d max in our case can be estimated as ≤ 30nm, so that V N A = 4 3 π 15 3 nm 3 6 * 10 23 mol −1 = 8482M −1 . This means that when the concentration of ubiquitylated cargo is [UC] = 1nM = 10 −9 M, only one in one hundred thousand adaptors will be able to bind cargo, while the remainder are inactivated intramolecularly. Even when the concentration of cargo is higher, e.g. in the high µM range in the case of free ubiquitin, the intermolecular complex will still be only a fraction of the intramolecular interaction.
These biophysical estimates indicate that ubiquitylated endocytic adaptor proteins in free solution will almost exclusively bind intramolecularly to their
